
Background:Adolescence is typically seen as a "healthy" period in a person's life, free from illness. The World Health Organisation (WHO) estimates that 1.7 million adolescents die every year because of preventable causes such as suicide, injuries, and violence. The aim of this quality improvement initiative was to assess and improve the use and documentation of the psychosocial risk assessment tool; HEEADSSS, amongst non-consultant hospital doctors (NCHDs) in a paediatric tertiary centre emergency department (ED). Methods:This was a mixed method quality improvement initiative carried out over three phases in paediatric tertiary centre ED. Educational interventions were implemented and their efficacy assessed. Results:There was a 277% (n = 9 increased to n = 34) improvement in the use and documentation of HEEADSSS in the post intervention phase of the study. Participants who had undertaken the intervention were significantly more likely to have either a partially or fully completed HEEADSSS assessment compared to those who had not (odds ratio [OR] = 5.24, 95% confidence interval [CI]: 3.45-7.75, p < 0.001; n = 409). Additionally, the odds of having a fully completed HEEADSSSassessment were significantly higher among those who received the intervention (OR = 4.08, 95% CI: 1.90-8.75, p < 0.001; n = 409). Clinical presentations synonymous with psychosomatic illness, such as chest pain, abdominal pain and headaches were more likely to have a HEEADSSS done following the intervention phase. Conclusion:The results demonstrate the efficacy of simple, accessible and education focused interventions. There is little documented in current literature about the efficacy of a proforma. In the field of adolescent medicine, there is a call for a multi-sectorial approach to be adapted, encompassing the educational, emotional, and financial needs of adolescents. Global health promotion strategies need to adjust to a prevention paradigm, focusing on the origin of adult mortality.
Background:The COVID-19 pandemic has escalated the utilization of virtual care platforms in pediatric diabetes mellitus. The impact of these interventions on the health-related quality of life (HRQOL) is unclear. Objective:This systematic review evaluated the impact of virtual care, including eHealth and mHealth modalities, when compared to in-person care, on HRQOL in children with diabetes. Methods:MEDLINE, EMBASE, EMCare, PsycInfo, and Web of Science, ProQuest Dissertations and Theses A&I, and ClinicalTrials.gov databases and registries were searched from database inception to October 2nd, 2023. Randomized and non-randomized comparative studies were eligible for inclusion. Results:Thirteen studies were identified (12 randomized controlled trials, 1 cross-sectional study) involving 1566 children with type 1 diabetes mellitus (T1DM). The supplemental virtual care interventions utilized either web- or mobile-based platforms for intervention implementation. No interventions were detrimental to HRQOL, and a few improved the short-term HRQOL. No interventions worsened glycemic control. Patients and family's satisfaction with virtual care was high, perceiving it to be equal to or better than in-person care. There was no evidence for the use of virtual care and its effect on HRQOL in pediatric type 2 diabetes mellitus patients. Conclusion:Virtual care is associated with a stable or improved HRQOL and patient and family satisfaction in pediatric T1DM. Decision makers need to consider expanding virtual access to pediatric diabetes care that can improve equitable access to quality care across healthcare systems globally.
Purpose:To assess the predictors of Chinese parents of girls' decision stage about the Human Papillomavirus (HPV) vaccination. Patients and Methods:Two hundred and seventy-three parents of girls aged 9-17 with no HPV vaccination history were recruited to complete an online survey between September-December 2023. We assessed factors thought to influence decisions about HPV vaccination, including sociodemographics, HPV general knowledge, HPV vaccination knowledge, attitudes, and decisional conflict. Parents were asked to choose the decision stages among Stage 1 (have not thought), Stage 2 (considering), and Stage 3 (decided). Predictors of the decision stage were assessed with univariate and multivariate multinomial logistic regression. Results:The parents of the three decision stages accounted for 48.4%, 29.7%, and 22.0%, respectively. Parents of older girls were more likely to be in the "considering" stage (OR = 1.29) than the "haven't thought" stage. A higher sense of being uninformed was associated with lower odds of being in the "considering" stage (OR = 0.97). Additionally, greater feelings of uncertainty were linked to lower odds of being in the "decided" stage (OR = 0.95) than the "haven't thought" stage. Conclusion:This study highlights the importance of understanding the various stages of decision-making in HPV vaccination among Chinese parents. Parents' subjective feelings of being informed and certainty appear to be significant factors in advancing through the decision-making stages. Future research should develop and explore the impact of specific knowledge and valued based tools and decision aids.
African immunization programs are crucial in reducing the prevalence of infectious diseases and improving public health outcomes. This review provides an overview of the current status of immunization efforts in Africa, highlights key challenges, and offers recommendations to help the continent achieve the 2030 Global Immunization Goals. While progress has been made, significant challenges remain. For instance, the WHO African Region reports full immunization coverage at 56.5%, partial coverage at 35.1%, and zero immunization coverage at 8.4%. Between 2019 and 2021, approximately 67 million children in Africa did not receive routine vaccinations, with West and Central Africa particularly affected. DTP1 coverage remained stable at 80%, but DTP3 coverage saw a slight drop to 72% between 2021 and 2022. As of 2022, MCV1 coverage reached 69%, reflecting ongoing efforts against measles. Key barriers to vaccination include limited parental education, religious beliefs, inadequate healthcare systems, and vaccine hesitancy. Addressing these barriers requires community-driven approaches like door-to-door campaigns and mobile clinics. To reach the 2030 immunization targets, health systems must be strengthened, vaccine supply chains optimized, and financial resources-both domestic and international-expanded. The Immunization Agenda 2030 (IA2030) emphasizes data-driven decision-making, nation-ownership, and tailored strategies to overcome obstacles and raise immunization coverage among several demographic groups. Achieving these 2030 goals in Africa requires collaborative efforts to ensure equitable access to vaccines, address sociocultural challenges, and strengthen health system infrastructure.
Background:Lower- and middle-income countries (LMICs) are disproportionately impacted by human papillomavirus (HPV) and would benefit from implementing the HPV vaccine. In the context of competing health priorities, utilizing scarce domestic infrastructure and human resources for HPV vaccination remains challenging for many LMICs. Given the high benefits of the HPV vaccine, the World Health Organization (WHO) is now encouraging for all countries, particularly LMICs, to introduce HPV vaccines into their routine immunization programs. Understanding the barriers and facilitators to HPV adolescent vaccine programs in LMICs may help strengthen how LMICs implement HPV vaccine programs, in turn, increasing HPV vaccine acceptance, uptake, and coverage. Objective:To identify and assess barriers and facilitators to implementing adolescent HPV vaccination programs in LMICs. Methods:This study comprised a review of literature assessing adolescent HPV vaccination in LMICs published after 2020 from a sociocultural perspective. Results:Overall, the findings showed that LMICs should prioritize increasing HPV vaccine availability and HPV vaccine knowledge, particularly focusing on cancer prevention, as knowledge reduces misinformation and increases vaccine acceptance. Evidence suggests that factors promoting HPV vaccine uptake include fostering low vaccine hesitancy, integrating HPV vaccination as a primary school routine vaccination, and vaccinating both genders. A one-dose HPV vaccine may enable many LMICs to increase vaccine acceptance, uptake, and coverage while controlling financial, infrastructure, and human resource costs. Conclusion:As HPV is one of the leading causes of death in many LMICs, implementing the HPV vaccine may be highly beneficial. Cohesive national HPV vaccine buy-in and understanding the success and challenges of prior LMIC HPV vaccine implementation is crucial to developing effective, efficient, and sustainable HPV vaccination programs.